Liver cancer, which is also known as hepatocellular carcinoma (HCC), and intrahepatic bile duct cancer is diagnosed in an estimated 26,190 people in the United States alone in 2011, and 19,590 people died from the disease.¹ Certain medical conditions predispose people to developing liver cancer, including infection with viral hepatitis, alcoholism, liver disease associated with diabetes, and morbid obesity. Hepatitis C virus (HCV), which affects at least 4 million Americans, accounts for most cases of liver cancer in the United States.